Archive
HIV Prevention Shot Lenacapavir: Aspen Warns of Demand Risks
Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.
Read More
SA Professional Stress Index: A New Persistent Reality
The SA Professional Stress Index reveals a troubling reality of prolonged stress for professionals in South Africa. Learn more.
Read More
African Health Funding Shift: Nonprofits Battle Aid Declines
In East London, Lesley-Ann Foster is packing away decades of patient records. Her nonprofit, Masimanyane Women’s Rights International, is facing a crisis. This situation is becoming common across the continent. A massive shift in African health funding is fundamentally changing how medical services are delivered to the most vulnerable.
Read More
Afrigen Business Rescue: Cape Town Biotech Firm Seeks Investors
Cape Town biotech firm Afrigen’s business rescue begins as the WHO-backed mRNA hub seeks new investment to secure vaccine manufacturing.
Read More
NHI Act Implementation: Addressing Healthcare Gaps
The pause in NHI Act implementation opens a window to improve South Africa’s healthcare infrastructure. Discover its implications.
Read More
The Global Funding Crisis: Rebuilding Multilateral Institutions
Examine the consequences of the Global Funding Crisis on multilateral health institutions and their role in global health equity.
Read More
Health Department Suspensions Follow Senior Official’s Arrests
Health Minister Aaron Motsoaledi confirms suspensions in the Health Department after fraud arrests involving the Global Fund.
Read More
Aspen Pharmacare Asset Disposals: Future Opportunities
Learn about potential Aspen Pharmacare asset disposals aimed at optimising the company’s global operations for greater profitability.
Read More
Chronic Respiratory Diseases: A Silent Health Crisis
Across South Africa and the globe, a silent scourge is devastating public health. Chronic respiratory diseases (CRDs), including asthma and chronic obstructive pulmonary disease (COPD), remain significantly underreported. Despite their prevalence, they receive far less attention than infectious diseases.
Read More
GEMS Contribution Increases Spark Talks With Unions
The GEMS contribution increases have sparked tensions with public-sector unions. Discover the details surrounding this issue.
Read More
Generic Semaglutide Pricing Could Disrupt Global Markets
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
Read More
FDA Biosimilar Development Guidance Targets Treatment Costs
Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.
Read More